NeoTherapeutics Inc., of Irvine, Calif., said it received a U.S. patent covering its hypoxanthine-based bifunctional molecule technology platform.
NexMed Inc., of Robbinsville, N.J., said it received U.S. Patent No. 6,224,573. It covers the dispenser used in the packaging of Alprox-TD and Femprox creams for erectile dysfunction and female sexual arousal disorder.
SciClone Pharmaceuticals Inc., of San Mateo, Calif., said it received a notice of allowance for a U.S. patent covering newly described analogues of its lead drug, Zadaxin.
The Immune Response Corp., of Carlsbad, Calif., said it received U.S. Patent No. 6,221,352. It covers claims related to the use of antibodies to target specific T-cell receptors to treat rheumatoid arthritis.
Tripos Inc., of St. Louis, said it received U.S. Patent No. 6,208,942 titled ¿Molecular Hologram QSAR.¿ It covers Tripos technology for the automatic examination of molecules to identify their structural characteristics responsible for biological activity.
ValiGen N.V., of Newtown, Pa., said it received U.S. Patent No. 6,221,585. It covers 55 claims related to the company¿s gene identification technology.